KoNECT – Syneos Health Global Drug Development Workshop

Join us for a series virtual workshops - with the Korea National Enterprise for Clinical Trials (KoNECT) – addressing key challenges faced by Korea biopharmaceutical companies developing rare disease therapies. Each live 90-minute session will feature brief presentations on a variety of topics as well as Q&A. 

DATES AND TIMES:

September 7, 8, 9, 2021 – 9:00 am – 10:30 am KST (Seoul)

September 6, 7, 8, 2021 – 8:00 pm – 9:30 pm EDT (US)

September 7, 8, 9, 2021 – 2:00 am – 3:30 am CEST (Europe)

REGISTER NOW

Featured Sessions

Day 1

(1.5 hours)

Shortening the distance from lab to life®
研究開発から実用化までの距離を縮める 

• Sora Lee, Vice President, General Manager Korea

An Overview of the Western Rare Disease Market 

• Dr. Raymond Huml, Vice President and Head of the Rare Disease Consortium

An Overview of Rare Disease Patient Recruitment Strategies in Korea, and Beyond  

• Helen Green, Director, Site and Patient Access

Q&A

• Presenters and Sunny Han, Director, Clinical Operations 

Day 2

(1.5 hours)

Navigating the Regulatory Landscape for Rare Diseases and Orphan Drugs in the EU 

• Allison Gillespie, Vice President, Regulatory Affairs

Global Impact of US FDA Initiatives to Support Orphan Drug Disease Development 

• Zohra Lomri, Executive Director, Global Regulatory Consulting

Q&A

• Presenters and Jinhak Kim, Director, SSU and Regulatory

Day 3

(1.5 hours)

Rare Disease Case Studies in Cell and Gene Therapy: Oncology, CNS, Ophthalmology 

• Pete Robinson, Vice President and Head of the Cell & Gene Therapy Consortium

How Competition Affects Market Access for Rare Disease Therapeutics 

• Keith Kelly, Sr. Managing Director, Consulting
• Fang Xu, Sr. Consultant, Consulting

The Critical, Multidimensional Role of Patient Advocacy Groups in Rare Disease Drug Development 

• Keri McDonough, Vice President and Head, Patient Voice Consortium

Q&A

• Presenters and Paul Park, Senior Director, Clinical Development
•  Jung Ok Jang, Project Director